NAME : MR. GOVTHAMAN.
R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
AGARAM NALAM PACKAGE 5
DEPARTMENT OF HAEMATOLOGY
COMPLETE BLOOD COUNT -5 P
TOTAL RBC COUNT 4.81 Million/cmm 4.50 - 6.50
HAEMOGLOBIN-HB 13.3 gm% 13.000 - 17.000
PCV 40.9 % 40 - 50
MCV 85.2 fl 83 - 101
MCH 27.7 pg 27 - 32
MCHC 32.6 g/l 31.5 - 34.5
RED CELL DISTRIBUTION WITH CV 12.4 % 11.5 - 15
TOTAL WBC COUNT - TC 6020 CELL\CUMM 4000 - 10000
DIFFERENTIAL COUNT
NEUTROPHIL 47.8 % 40 - 75
LYMPHOCYTES 44.0 % 20 - 40
EOSINOPHILS 1.7 % 1-6
MONOCYTES 6.3 % 1 - 10
BASOPHILS 0.2 % <2
ABSOLUTE NEUTROPHIL COUNT 2880.0 cells/micro L 2000 - 7000
ABSOLUTE LYMPHOCYTE COUNT 2650.0 1000 - 4000
ABSOLUTE EOSINOPHIL COUNT 100.0 Cells/microL 40 - 440
ABSOLUTE MONOCYTE COUNT 380.0 cells/micro L 200 - 1000
ABSOLUTE BASOPHIL COUNT 10.0 cells/micro L < 150
PLATELET COUNT 324 THOUSAND/UL 150 - 410 THOUSAND
PLATELETCRIT 29.5 % 19.7 - 42.4
MEAN PLATELET VOLUME - MPV 9.1 fL 6.5 - 12.0
PLATELET DISTRIBUTION WIDTH - SD 10.5 fL 9.2 - 16.7
Page 1 of 7
NAME : MR. GOVTHAMAN.R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
PLATELET TO LARGE CELL RATIO - PLCR 28.9 % 19.7 - 42.4 %
INTERPRETATION
As per the recommendation of international carnal in hematology , the differential leukocyte count are additionally begging
reported as absolute number in ache cell for unit volume of blood.
Test concluded on whole blood EDTA.
DEPARTMENT OF BIOCHEMISTRY
BLOOD GLUCOSE FASTING 98.0 mg/dl Diabetes: > 126 and above
(Method: GOD-POD) Prediabetes: 100 - 125
Normal: Less than 100
INTERPRETATION
Limitations :
Most glucose strips and meters quantify whole blood glucose, whereas most laboratories use plasma or serum which reads 10-
15% higher.
Blood samples in which serum is not separated from blood cells shows glucose values decreasing at rate of 3-5% per hour at room
temperature
Strenuous exercise, strong emotions, shock, burns and infections can increase glucose physiologically.
Low oxygen content (e.g,venous blood, high altitudes >3000 mts) gives falsely increased values.
HbA1c
(Method: HPLC)
GLYCOSYLATED HAEMOGLOBIN - HbA1c 5.5 % Below 5.6 - Non diabetic Level
Impaired glucose tolerance: 5.7
- 6.4
Above 6.5 - Diabetes
MEAN PLASMA GLUCOSE - MPG 118.5 mg/dl
ESTIMATED AVERAGE GLUCOSE - eAG 111.15 mg/dl
INTERPRETATION
HbA1c level reflects the mean glucose concentration over the previous period (approximately 6-8 weeks) and provides a much
better indication of long term glycemic control than blood and urine glucose determinations. The American Diabetes Association
recommends measurement of HbA1c every 3 months to determine whether a patient’s metabolic control has remained
continuously within the target range.A1C test should be performed at least 2 times a year in patients who are meeting treatment
goals (and who have stable glycemic control). A1C test should be performed quarterly in patients whose therapy has changed or
who are not meeting glycemic goals. Predicting development and progression of diabetic microvascular complications. This assay
is not useful in determining day to day glucose control and should not be used to replace routine blood glucose testing.
LIPID PROFILE
TOTAL CHOLESTEROL 205.0 mg/dl Desirable blood Choesterol: <
(Method: CHOD-PAP) 200
Boderline high blood
cholesterol: 200 - 239
High blood Cholesterol: >239
Page 2 of 7
NAME : MR. GOVTHAMAN.R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
TRIGLYCERIDES 124.0 mg/dl Normal: 0.1 - 160
(Method: GPO/ENZYMATIC) High: 161 - 199
Hypertriglyceridemic: 200 - 499
Very High: > 499
HDL CHOLESTEROL - DIRECT 47.0 mg/dl 35.3 - 79.5
(Method: DIRECT CLEARANCE)
LDL CHOLESTEROL - DIRECT 133.2 mg/dl < 130
(Method: DIRECT CLEARANCE)
NON HDL CHOLESTEROL 158.0 < 140
VLDL 24.8 < 35
LDL / HDL RATIO 2.83 High risk: More than - 6.0
Borderline: 3.0 - 4.0
Optimal: Less than - 3.0
CHOL / HDL RATIO 4.36 3.9 - 5
TGL / HDL RATIO 2.64 <2
INTERPRETATION
The CHD risk is based on T.CHOL/ HDL ratio. Other factors affect CHD risk such as Hypertension, smoking, diabetes, severe
obesity and family history of premature CHD.
LIVER FUNCTION TEST
BILIRUBIN TOTAL 0.49 mg/dl < 1.2
(Method: JENDRASSIK ) Infant ( < 1D ): 2.0 - 6.0
Infant (1D - 2D ): 6.0 - 10.0
Infant (3D - 5D ): 4.0 - 8.0
BILIRUBIN DIRECT 0.25 mg/dl < 0.40
(Method: DIAZO)
BILIRUBIN INDIRECT 0.24 mg/dl 0.25 - 1
SGOT - AST 17.0 U/L 0.0 - 35.0
(Method: IFCC / KINETIC)
SGPT - ALT 20.0 U/L Upto - 45
(Method: IFCC / KINETIC)
AST/ALT RATIO 0.85
ALKALINE PHOSPHATASE 86.0 U/L 53 - 128
Page 3 of 7
NAME : MR. GOVTHAMAN.R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
GAMMA GT ( GAMMA GLUTAMYL 18.0 IU/L <55.0
TRANSPEPTIDASE )
(Method: KINETIC)
TOTAL PROTEIN 7.1 gm/dl 6.2 - 8.0
(Method: BIURET)
ALBUMIN 4.0 gm/dl 3.5 - 5.2
(Method: BROMO CRESOL GREEN)
GLOBULIN 3.1 gm/dl 2.3 - 3.5
A/G RATIO 1.29 1-2
INTERPRETATION
Clinical Use :
- High levels of GGT in the blood may be a sign of liver disease or damage to the bile ducts.
- Bile ducts are tubes that carry bile in and out of the liver. Bile is a fluid made by the liver.
- It is important for digestion
Most causes of liver cell injury are associated with a greater increase in ALT than AST; however, an AST to ALT ratio of 2:1 or
greater is suggestive of alcoholic liver disease, particularly in the setting of an elevated gamma-glutamyl transferase.
CARDIAC RISK MARKERS
APOLIPOPROTEIN - A1 146.0 mg/dl 122 - 161
(Method: Immunoturbidimetric)
INTERPRETATION
An apolipoprotein is a protein component of lipoprotein that regulates their metabolism and each of four major groups consists of
a family of two or more immunologically distinct proteins. Apolipoprotein A is the major protein of HDL. Apolipoprotein B is major
protein component of low density lipoprotein and is important in regulating cholesterol synthesis and metabolism.
USE :
To evaluate the risk of CAD. Levels of apo A-1 are inversely associated with premature cardiovascular disease and peripheral
vascular disease. The ratio of apo A to apo B has greater sensitivity and specificity for CAD then individual lipid or lipoproteins.
APOLIPOPROTEIN - B 101.0 mg/dl 69 - 105
(Method: Immunoturbidimetric)
APO B/APO A1 RATIO 0.69 Ratio 0.35 - 1.0
LIPOPROTEIN - a 24.0 mg/dL Upto 30
(Method: Particle enhanced
immunoturbidimetric assay)
hs C-REACTIVE PROTEIN 2.8 mg/L Infant (0 W - 3 W ): 0.1 - 4.1
(Method: SPECTROPHOTOMETRY) Child (2 M - 15 Y ): 0.1 - 2.8
Adult: Less than 5.0 (Particle
enhanced immunoturbidimetric
assay)
INTERPRETATION
Use :
Page 4 of 7
NAME : MR. GOVTHAMAN.R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
Hs CRP may be useful as an independent marker of prognosis for recurrent events in patients with stable coronary disease or
acute coronary syndrome.
Hs CRP is additive with total and high density lipoprotein cholesterol with respect to risk prediction.Assessment of risk of
developing myocardial infarction in patients presenting with acute coronary syndromes. Assessment of risk of developing
cardiovascular disease or ischemic events in individuals who do not have manifest disease at present.
HOMOCYSTEINE 27.0 umol/L < 15
(Method: Enzymatic)
INTERPRETATION
Use :
Homocysteine is an independent predictor of cardiovascular disease (atherosclerosis, heart disease,thromboembolism) as an
indicator of acquired folate or cobalamin deficiency and a contributing factor in the pathogenesis of neural tube defects.
Hyperhomocysteinemia suggests that genetic and nutritional factors are potentially involved in the etiology of the disease.
Response to dietery treatment can be evaluated by monitoring homocysteine over time.
Elevated levels of homocysteine may be used to exclude or confirm deficiencies of VitaminB12 or folate.Elevations in
homocysteine levels have also been used as an independent risk factor of coronary or cerebral vascular disease
RENAL FUNCTION TEST
GLOMERULAR FILTRATION RATE - eGFR 122.0 ml/min/1.73 Less than 60 - is abnormal
m2 (MDRD)
BUN/CREATININE RATIO 15.18 10 - 20.1
BLOOD UREA NITROGEN - BUN 12.6 mg/dl 05 - 20
(Method: UREASE / GLDH)
URIC ACID 7.2 mg/dl 3.5 - 7.2
(Method: URICASE/PEROXIDASE)
CREATININE 0.83 mg/dl 0.7 - 1.3
(Method: ENZYMATIC)
UREA 27.0 mg/dl 10 - 50
(Method: ENZYMATIC)
DEPARTMENT OF IMMUNOLOGY
THYROID FUNCTION TEST
TOTAL TRIIODOTHYRONINE - T3 1.21 ng/mL 0.60 - 1.81
(Method: CLIA)
TOTAL THYROXINE - T4 7.65 ug/dl 4.50 - 10.9
(Method: CLIA)
Page 5 of 7
NAME : MR. GOVTHAMAN.R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
THYROID STIMULATING HORMONE - TSH 4.86 uIU/ml 0.35 - 4.75
(Method: CLIA)
INTERPRETATION
TSH Levels are subjected to circadrain variations reaching peak levels between 2-4 am and at a minimum between 6-10
pm. The variation is of order of 50% hence time of day has influence of TSH measurements.
TSH values < 0.03 u/l/ml need to be clinically correlated due to presence of rare TSH variant in some individuals.
Pregnancy : First trimester : 0.3 - 4.5, Second trimester: 0.5 - 4.6, Third trimester : 0.8 - 5.2
Clinical Clinical Use
* Primary Hypothyroidism
* Hyperthyroidism
* Hypothalamic – Pituitary hypothyroidism
* Inappropriate TSH secretion
* Nonthyroidal illness
* Autoimmune thyroid disease
* Pregnancy associated thyroid disorders
* Thyroid dysfunction in infancy and early childhood
VITAMIN B12 617.5 pg/ml 211 - 911
(Method: CLIA)
INTERPRETATION
Low vitamin B12 values may cause megaloblastic anemia and/or peripheral neuropathies.A normal serum concentration of vitamin
B12 does not rule out tissue deficiency of Vitamin B12.If clinical symptoms suggest deficiency, measurement of Homocysteine
should be considered even if serum vitamin B12 concentrations are normal. Patients taking Vitamin B12 may have misleading
results. Many other conditions are known to cause an increase (vitamin C, vitamin A, estrogens, hepatocellular injury,
myeloproliferative disorders,uremia) or decrease (pregnancy,smoking, hemodialysis, multiple myeloma) serum levels.
VITAMIN D TOTAL (25-OH) 18.9 ng/ml Deficient: <20
(Method: CLIA) Insuffcient: 20 - <30
Suffcient: 30 - 100
Upper Safety Limit: >100
INTERPRETATION
Comments :
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency in children causes
Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and Tetany. Vitamin D status is best determined by
measurement of 25 hydroxy vitamin D, as it is the major circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy
vitamin D (5-8 hrs).
Decreased Levels :
Inadequate exposure to sunlight
· Dietary deficiency
· Vitamin D malabsorption
· Severe Hepatocellular disease
· Drugs like Anticonvulsants
· Nephrotic syndrome
Increased levels
. Vitamin D intoxication
Page 6 of 7
NAME : MR. GOVTHAMAN.R
ID : AD-124626
AGE/GENDER : 29 years 0 months/M
RECEIVED : 09/03/2025 09:47
DOB : 02/03/1996
ANALYSED : 09/03/2025 09:51
REFERRED BY : SELF
REPORTED : 09/03/2025 14:25
PHONE : 8870000568
Test Name Findings Units Bio Ref.Interval
--- End of the Report ---
Mr. GUNASEKARAN A M , M.Sc,
Biochemistry
QUALITY MANAGER
APPROVED BY
Page 7 of 7
